Home/Filings/4/0001567619-23-006692
4//SEC Filing

Insud Pharma S.L. 4

Accession 0001567619-23-006692

CIK 0001822691other

Filed

Jul 25, 8:00 PM ET

Accepted

Jul 26, 9:18 PM ET

Size

7.2 KB

Accession

0001567619-23-006692

Insider Transaction Report

Form 4
Period: 2023-07-24
Transactions
  • Other

    Common Stock, par value $0.0001 per share

    2023-07-242,551,0200 total
Footnotes (1)
  • [F1]The Reporting Person contributed its shares of common stock, par value $0.0001 per share (the "Common Stock"), to SW ParentCo, Inc. ("Parent") in exchange for shares of Series A-2 Preferred Stock, par value $0.001 per share, of Parent pursuant to the Contribution and Exchange Agreement dated May 29, 2023, between Reporting Person and Parent in connection with the closing of the transactions contemplated by the Agreement and Plan of Merger (the "Merger") among Issuer, Parent and SW MergerCo, Inc. ("Merger Sub") on July 24, 2023, pursuant to which Merger Sub merged with and into the Issuer, with the Issuer surviving as a wholly-owned subsidiary of Parent.

Documents

1 file

Issuer

GreenLight Biosciences Holdings, PBC

CIK 0001822691

Entity typeother
IncorporatedSpain

Related Parties

1
  • filerCIK 0001980616

Filing Metadata

Form type
4
Filed
Jul 25, 8:00 PM ET
Accepted
Jul 26, 9:18 PM ET
Size
7.2 KB